News

DIRTT Environmental Solutions Launches NCIB for Debentures

DIRTT Environmental Solutions Launches NCIB for Debentures

DIRTT Environmental Solutions Announces Normal Course Issuer Bid

DIRTT Environmental Solutions Ltd. (TSX: DRT; OTC: DRTTF) has made an important announcement regarding its financial strategy. As a leader in industrialized construction, the company has received approval from the Toronto Stock Exchange (TSX) for its normal course issuer bid (NCIB), which aims to buy back its 6.00% convertible unsecured subordinated debentures maturing on January 31, 2026, and its 6.25% convertible unsecured subordinated debentures maturing on December 31, 2026.

Details of the Normal Course Issuer Bid

The NCIB is set to begin soon and is intended to enable DIRTT to acquire a specific amount of its outstanding debentures. Through this program, DIRTT plans to repurchase up to C$1,664,200 in principal amount of the January Debentures and C$1,558,700 in principal amount of the December Debentures. This represents 10% of the public float for each type of debenture, with the total outstanding amounts being C$16,642,000 for January Debentures and C$15,587,000 for December Debentures as of a recent date.

Daily Purchase Limitations

The company is mindful of the regulations regarding purchase limits. DIRTT will ensure that it does not buy more than C$111,507 in principal amount of the January Debentures or C$416,071 in principal amount of the December Debentures on any trading day. These maximum daily purchases account for approximately 25% of the average daily trading volume calculated over the last six months.

Market Impact and Strategic Flexibility

The launch of the NCIB highlights DIRTT's dedication to maintaining strategic flexibility in its capital allocation. Purchases will occur through open market transactions, and any debentures bought back will be cancelled immediately after acquisition. This approach allows DIRTT to manage its capital effectively while taking advantage of favorable market conditions.

Previous Debenture Repurchases

DIRTT has a history of proactive financial strategies. Earlier this year, the company completed a significant transaction where it repurchased a considerable amount of its debentures, reaffirming its commitment to enhancing shareholder value. In a previous issuer bid, DIRTT successfully repurchased C$4,693,000 of January Debentures and C$5,775,000 of December Debentures for cancellation.

Seeking Approval for Repurchase Plans

Alongside the NCIB, DIRTT is expected to implement an issuer repurchase plan agreement (IRPA) and an automatic repurchase plan agreement (ARPP). These plans are designed to facilitate strategic purchases of the debentures, particularly during times when normal trading restrictions may limit their ability to do so.

About DIRTT Environmental Solutions

Based in Calgary, DIRTT Environmental Solutions is a leader in the industrialized construction sector. Their innovative approach combines physical products with digital tools, enabling organizations in various fields, including healthcare, education, and public spaces, to create customized interior environments. DIRTT’s flexible solutions empower clients to easily reconfigure their spaces, improving both functionality and efficiency.

Investor Relations Contact

For more information about the normal course issuer bid or other company matters, DIRTT invites investors and interested parties to contact their Investor Relations team directly via email.

Frequently Asked Questions

What is a normal course issuer bid (NCIB)?

A normal course issuer bid (NCIB) is a program that allows a company to buy back its own shares from the open market to effectively manage its capital structure.

Why is DIRTT implementing the NCIB?

DIRTT is implementing the NCIB to gain flexibility in managing its capital and to take advantage of market conditions that may present opportunities for repurchasing its debentures.

How much capital is DIRTT planning to allocate for the NCIB?

DIRTT has allocated a total principal amount of up to C$1,664,200 for January Debentures and C$1,558,700 for December Debentures as part of the NCIB.

What are the restrictions on daily purchases under the NCIB?

The company is limited to purchasing no more than C$111,507 of January Debentures and C$416,071 of December Debentures on any trading day.

How has DIRTT previously managed its debentures?

DIRTT has previously engaged in significant repurchase transactions, including a successful issuer bid earlier this year, demonstrating its commitment to shareholder value and sound financial management.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading